Capital Investment Counsel Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Buy |
31,190
+30,985
| +15,115% | +$2.57M | 0.34% | 50 |
|
|
2025
Q1 | $16.6K | Hold |
205
| – | – | ﹤0.01% | 235 |
|
|
2024
Q4 | $18.5K | Hold |
205
| – | – | ﹤0.01% | 237 |
|
|
2024
Q3 | $20.3K | Hold |
205
| – | – | ﹤0.01% | 217 |
|
|
2024
Q2 | $19K | Hold |
205
| – | – | ﹤0.01% | 216 |
|
|
2024
Q1 | $19.5K | Hold |
205
| – | – | ﹤0.01% | 212 |
|
|
2023
Q4 | $18.3K | Hold |
205
| – | – | ﹤0.01% | 211 |
|
|
2023
Q3 | $15K | Buy |
+205
| New | +$15K | ﹤0.01% | 204 |
|
|
2020
Q3 | – | Sell |
-3,011
| Closed | -$337K | – | 189 |
|
|
2020
Q2 | $337K | Sell |
3,011
-1,625
| -35% | -$182K | 0.13% | 89 |
|
|
2020
Q1 | $359K | Buy |
4,636
+200
| +5% | +$15.5K | 0.14% | 94 |
|
|
2019
Q4 | $422K | Sell |
4,436
-25
| -0.6% | -$2.38K | 0.14% | 100 |
|
|
2019
Q3 | $340K | Buy |
4,461
+250
| +6% | +$19.1K | 0.12% | 106 |
|
|
2019
Q2 | $369K | Buy |
4,211
+150
| +4% | +$13.1K | 0.13% | 108 |
|
|
2019
Q1 | $368K | Sell |
4,061
-150
| -4% | -$13.6K | 0.14% | 108 |
|
|
2018
Q4 | $302K | Hold |
4,211
| – | – | 0.13% | 106 |
|
|
2018
Q3 | $404K | Sell |
4,211
-25
| -0.6% | -$2.4K | 0.15% | 96 |
|
|
2018
Q2 | $403K | Buy |
4,236
+200
| +5% | +$19K | 0.16% | 93 |
|
|
2018
Q1 | $354K | Buy |
4,036
+100
| +3% | +$8.77K | 0.15% | 100 |
|
|
2017
Q4 | $334K | Sell |
3,936
-300
| -7% | -$25.5K | 0.14% | 101 |
|
|
2017
Q3 | $367K | Sell |
4,236
-325
| -7% | -$28.2K | 0.16% | 100 |
|
|
2017
Q2 | $352K | Sell |
4,561
-225
| -5% | -$17.4K | 0.16% | 101 |
|
|
2017
Q1 | $332K | Buy |
4,786
+250
| +6% | +$17.3K | 0.15% | 104 |
|
|
2016
Q4 | $268K | Buy |
+4,536
| New | +$268K | 0.13% | 116 |
|